Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Share-based Compensation (2021 - 2026)

HeartSciences' Share-based Compensation history spans 6 years, with the latest figure at -$503107.0 for Q1 2026.

  • For Q1 2026, Share-based Compensation changed N/A year-over-year to -$503107.0; the TTM value through Jan 2026 reached $268926.0, up 203.9%, while the annual FY2025 figure was $170637.0, 57.87% down from the prior year.
  • Share-based Compensation reached -$503107.0 in Q1 2026 per HSCS's latest filing, down from $436884.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $436884.0 in Q4 2025 to a low of -$503107.0 in Q1 2026.
  • Average Share-based Compensation over 5 years is $66552.2, with a median of $99154.0 recorded in 2023.
  • Peak YoY movement for Share-based Compensation: surged 8956.68% in 2022, then tumbled 98.69% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $1918.0 in 2022, then surged by 5418.25% to $105840.0 in 2023, then tumbled by 90.51% to $10046.0 in 2024, then skyrocketed by 4248.84% to $436884.0 in 2025, then plummeted by 215.16% to -$503107.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Share-based Compensation are -$503107.0 (Q1 2026), $436884.0 (Q4 2025), and $174558.0 (Q3 2025).